Management of NMIBC during BCG shortage and COVID ‐19

Shortages ofBacille Calmette ‐Guérin (BCG) have implications for the management of patients with non ‐muscle‐invasive bladder cancers. Further complications come as a result of COVID‐19 for which BCG also shows some promising prospects.
Source: Trends in Urology and Men's Health - Category: Urology & Nephrology Authors: Tags: Bladder cancer Source Type: research